AtriCure, Inc.
NASDAQ:ATRC
36 (USD) • At close September 8, 2025
 Overzicht | Financiële gegevens
 | Bedrijfsnaam | AtriCure, Inc. | 
| Symbool | ATRC | 
| Munteenheid | USD | 
| Prijs | 36 | 
| Beurswaarde    |  1,789,250,400 | 
| Dividendpercentage    |  0% | 
| 52-weken bereik | 25.57 - 43.11 | 
| Industrie | Medical Instruments & Supplies | 
| Sector | Healthcare | 
| CEO | Mr. Michael H. Carrel | 
| Website | https://www.atricure.com | 
An error occurred while fetching data.
Over AtriCure, Inc.
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as 
 Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)







